[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Molecular Diagnostics in Infectious Disease Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 120 pages | ID: GAC8E66CDE7GEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.

SCOPE OF THE REPORT:

This report studies the Molecular Diagnostics in Infectious Disease Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Diagnostics in Infectious Disease Testing market by product type and applications/end industries.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Technological advancement in diagnostic procedures for infectious diseases, the increasing prevalence of infectious diseases, a growing elderly population, and the growth of research activities in molecular diagnostic technologies are some major drivers for the global molecular diagnostics in infectious disease testing market.
The global Molecular Diagnostics in Infectious Disease Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Molecular Diagnostics in Infectious Disease Testing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
  • Abbott
  • BD
  • BioMerieux
  • Thermo Fisher Scientific
  • Roche
  • Siemens
  • Veridex
  • Luminex
  • GenMark Diagnostics
  • Qiagen
  • Genomix Biotech
  • BioTheranostics
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microarrays
  • Next-Generation Sequencing (NGS)
  • Hybridization
  • Others
Market Segment by Applications, can be divided into
  • Hospitals
  • Clinics
  • Academic Institutes
  • Laboratories
  • Others
1 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET OVERVIEW

1.1 Product Overview and Scope of Molecular Diagnostics in Infectious Disease Testing
1.2 Classification of Molecular Diagnostics in Infectious Disease Testing by Types
  1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue Comparison by Types (2017-2023)
  1.2.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Types in 2017
  1.2.3 Polymerase Chain Reaction (PCR)
  1.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
  1.2.5 Microarrays
  1.2.6 Next-Generation Sequencing (NGS)
  1.2.7 Hybridization
  1.2.8 Others
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market by Application
  1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Academic Institutes
  1.3.5 Laboratories
  1.3.6 Others
1.4 Global Molecular Diagnostics in Infectious Disease Testing Market by Regions
  1.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Molecular Diagnostics in Infectious Disease Testing (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Abbott
  2.1.1 Business Overview
  2.1.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 BD
  2.2.1 Business Overview
  2.2.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 BD Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 BioMerieux
  2.3.1 Business Overview
  2.3.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Thermo Fisher Scientific
  2.4.1 Business Overview
  2.4.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
  2.5.1 Business Overview
  2.5.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Siemens
  2.6.1 Business Overview
  2.6.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Veridex
  2.7.1 Business Overview
  2.7.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Luminex
  2.8.1 Business Overview
  2.8.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 GenMark Diagnostics
  2.9.1 Business Overview
  2.9.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Qiagen
  2.10.1 Business Overview
  2.10.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genomix Biotech
  2.11.1 Business Overview
  2.11.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 BioTheranostics
  2.12.1 Business Overview
  2.12.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET COMPETITION, BY PLAYERS

3.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Molecular Diagnostics in Infectious Disease Testing Players Market Share
  3.2.2 Top 10 Molecular Diagnostics in Infectious Disease Testing Players Market Share
3.3 Market Competition Trend

4 GLOBAL MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SIZE BY REGIONS

4.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Regions
4.2 North America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.5 South America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING REVENUE BY COUNTRIES

5.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
5.2 USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)

6 EUROPE MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING REVENUE BY COUNTRIES

6.1 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
6.2 Germany Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.3 UK Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.4 France Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING REVENUE BY COUNTRIES

7.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
7.2 China Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.5 India Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING REVENUE BY COUNTRIES

8.1 South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
8.2 Brazil Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING BY COUNTRIES

9.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)

10 GLOBAL MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENT BY TYPE

10.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Type (2018-2023)
10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2013-2023)
10.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Growth Rate (2013-2023)
10.5 Microarrays Revenue Growth Rate (2013-2023)
10.6 Next-Generation Sequencing (NGS) Revenue Growth Rate (2013-2023)
10.7 Hybridization Revenue Growth Rate (2013-2023)
10.8 Others Revenue Growth Rate (2013-2023)

11 GLOBAL MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SEGMENT BY APPLICATION

11.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2013-2018)
11.2 Molecular Diagnostics in Infectious Disease Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Academic Institutes Revenue Growth (2013-2018)
11.6 Laboratories Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)

12 GLOBAL MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SIZE FORECAST (2018-2023)

12.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast (2018-2023)
12.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Regions (2018-2023)
12.3 North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.4 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.6 South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source



LIST OF TABLES AND FIGURES

Figure Molecular Diagnostics in Infectious Disease Testing Picture
Table Product Specifications of Molecular Diagnostics in Infectious Disease Testing
Table Global Molecular Diagnostics in Infectious Disease Testing and Revenue (Million USD) Market Split by Product Type
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Types in 2017
Figure Polymerase Chain Reaction (PCR) Picture
Figure Isothermal Nucleic Acid Amplification Technology (INAAT) Picture
Figure Microarrays Picture
Figure Next-Generation Sequencing (NGS) Picture
Figure Hybridization Picture
Figure Others Picture
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Application (2013-2023)
Figure Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Academic Institutes Picture
Figure Laboratories Picture
Figure Others Picture
Table Global Market Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Abbott Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table BD Basic Information, Manufacturing Base and Competitors
Table BD Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table BD Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table BioMerieux Basic Information, Manufacturing Base and Competitors
Table BioMerieux Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Roche Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Basic Information, Manufacturing Base and Competitors
Table Siemens Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Siemens Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Veridex Basic Information, Manufacturing Base and Competitors
Table Veridex Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Veridex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Luminex Basic Information, Manufacturing Base and Competitors
Table Luminex Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Luminex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table GenMark Diagnostics Basic Information, Manufacturing Base and Competitors
Table GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Genomix Biotech Basic Information, Manufacturing Base and Competitors
Table Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table BioTheranostics Basic Information, Manufacturing Base and Competitors
Table BioTheranostics Molecular Diagnostics in Infectious Disease Testing Type and Applications
Table BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Players (2013-2018)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players in 2016
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players in 2017
Figure Global Top 5 Players Molecular Diagnostics in Infectious Disease Testing Revenue Market Share in 2017
Figure Global Top 10 Players Molecular Diagnostics in Infectious Disease Testing Revenue Market Share in 2017
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Regions (2013-2018)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Regions (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Regions (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Regions in 2017
Figure North America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure South America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Table North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
Table North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2017
Figure USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Canada Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Mexico Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Table Europe Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Countries (2013-2018)
Figure Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2017
Figure Germany Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure UK Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure France Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Russia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Italy Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2017
Figure China Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Japan Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Korea Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure India Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Table South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
Table South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2017
Figure Brazil Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Argentina Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Colombia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2017
Figure Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure UAE Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Egypt Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure Nigeria Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Figure South Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Type (2013-2018)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Type (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Type (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Type in 2017
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue Forecast by Type (2018-2023)
Figure Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Type (2018-2023)
Figure Global Polymerase Chain Reaction (PCR) Revenue Growth Rate (2013-2018)
Figure Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Growth Rate (2013-2018)
Figure Global Microarrays Revenue Growth Rate (2013-2018)
Figure Global Next-Generation Sequencing (NGS) Revenue Growth Rate (2013-2018)
Figure Global Hybridization Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2013-2018)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application in 2017
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue Forecast by Application (2018-2023)
Figure Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Academic Institutes Revenue Growth Rate (2013-2018)
Figure Global Laboratories Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
Figure Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
Figure South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)


More Publications